Helminth Infection: Clinical Trials

2 trials for Helminth Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Withdrawn 1

Follow Helminth Infection: new trials by email Literature Review of Helminth Infection trials Research Report on Helminth Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Twice Yearly Treatment for the Control of LF
400 μg/kg Ivermectin + 400 mg Albendazole - Lymphatic Filariasis, Helminth Infection
Phase 4CompletedNoguchi Memorial Institute for Medical Research14622017-05-192020-02-26
Intestinal Microbiome Post-Azythromycin/Albendazole Treatment
Azithromycin, Albendazole, Delayed treatment - Helminth Infection
Phase 4WithdrawnUniversity of California, San Francisco2017-01-012021-06-28

Narrower conditions

Trematode Infections (2)  ·  Elephantiasis, Filarial (1)

Broader conditions

Helminthiasis (2)  ·  Infections (2)  ·  Parasitic Diseases (2)  ·  Filariasis (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphedema (1)  ·  Mosquito-Borne Diseases (1)  ·  Nematode Infections (1)  ·  Secernentea Infections (1)  ·  Spirurida Infections (1)  ·  Vector Borne Diseases (1)

Interventions

Albendazole (2)  ·  Azithromycin (1)  ·  Ivermectin (1)  ·  Treatment Delay (1)

Sponsors

Noguchi Memorial Institute for Medical Research (1)  ·  University of California, San Francisco (1)

Countries

Ethiopia (1)  ·  Ghana (1)

Top investigators

Dziedzom K de Souza, PhD (1)  ·  Jeremy Keenan, MD, MPH (1)

Results publications

PMID 28969715